These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35781215)

  • 1. Retraction Note to: Insights from diversified anti-angiogenic models: role of β-interferon inducer DEAE-Dextran.
    Bakrania AK; Variya BC; Patel SS
    Pharmacol Rep; 2022 Aug; 74(4):770. PubMed ID: 35781215
    [No Abstract]   [Full Text] [Related]  

  • 2. Insights from diversified anti-angiogenic models: Role of β-interferon inducer DEAE-Dextran.
    Bakrania AK; Variya BC; Patel SS
    Pharmacol Rep; 2018 Jun; 70(3):549-557. PubMed ID: 29677525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of β-Interferon Inducer (DEAE-Dextran) in Tumorigenesis by VEGF and NOTCH1 Inhibition along with Apoptosis Induction.
    Bakrania AK; Variya BC; Patel SS
    Front Pharmacol; 2017; 8():930. PubMed ID: 29311933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated dose 28-day oral toxicity study of DEAE-Dextran in mice: An advancement in safety chemotherapeutics.
    Bakrania AK; Variya BC; Madan P; Patel SS
    Regul Toxicol Pharmacol; 2017 Aug; 88():262-272. PubMed ID: 28694171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of interferon synthesis: effect of diethylaminoethyl-dextran on induction by polyinosinic-polycytidylic acid.
    Vilcek J; Barmak SL; Havell EA
    J Virol; 1972 Oct; 10(4):614-21. PubMed ID: 4343544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of combination of different inducers on the refractory state in interferon production.
    Yershov FI; Tazulakhova EB; Novokhatsky AS
    Acta Virol; 1976 Feb; 20(1):15-22. PubMed ID: 7936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The dynamics of 2',5'-oligoadenylate synthetase activity in the nuclear and cytoplasmic fractions of human fibroblasts treated by double-stranded RNAs, by their complexes with DEAE-dextran and by type-I recombinant interferons. The ratio of double-stranded RNA-activated and -nonactivated froms of the enzyme].
    Sokolova TM; Antonov AIu; Makhov AM
    Antibiot Khimioter; 1991 Jun; 36(6):31-5. PubMed ID: 1898186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative analysis of the action of an interferon inducer in in vitro and in vivo systems].
    Ershov FI; Novokhatskiĭ AS; Tazulakhova EB
    Antibiotiki; 1978 Jun; 23(6):557-62. PubMed ID: 209734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of DEAE-dextran-mediated gene transfer.
    Yang YW; Yang JC
    Biotechnol Appl Biochem; 1997 Feb; 25(1):47-51. PubMed ID: 9032935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of adhesive properties of DEAE-dextran with laminin.
    Varani J; Fligiel SE; Inman DR; Beals TF; Hillegas WJ
    J Biomed Mater Res; 1995 Aug; 29(8):993-7. PubMed ID: 7593043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of calcium ions in DEAE-dextran-induced stimulation of neutrophil migration.
    Elferink JG; de Koster BM
    Chem Biol Interact; 1995 Mar; 95(1-2):203-14. PubMed ID: 7697751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl-DEAE-dextran: a candidate biomaterial.
    Zambito Y; Baggiani A; Carelli V; Serafini MF; Di Colo G
    Biomed Mater Eng; 2004; 14(4):411-7. PubMed ID: 15472389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of a bivalent anti-foot-and-mouth disease vaccine with oil adjuvant to a vaccine with DEAE-dextran adjuvant in swine].
    Kihm U
    Dev Biol Stand; 1976; 35():149-53. PubMed ID: 198281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of DEAE-dextran-MMA graft copolymer as a nonviral gene carrier.
    Onishi Y; Eshita Y; Murashita A; Mizuno M; Yoshida J
    Nanomedicine; 2007 Sep; 3(3):184-91. PubMed ID: 17765639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of DEAE-dextran on infection and hemolysis by VSV. Evidence that nonspecific electrostatic interactions mediate effective binding of VSV to cells.
    Bailey CA; Miller DK; Lenard J
    Virology; 1984 Feb; 133(1):111-8. PubMed ID: 6199890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transglomerular transport of DEAE dextran in the isolated perfused kidney.
    Adal Y; Pratt L; Comper WD
    Microcirculation; 1994 Oct; 1(3):169-74. PubMed ID: 8790587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate-dependent differences in growth and biological properties of fibroblasts and epithelial cells grown in microcarrier culture.
    Varani J; Dame M; Rediske J; Beals TF; Hillegas W
    J Biol Stand; 1985 Jan; 13(1):67-76. PubMed ID: 2985616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking of interferon synthesis in murine macrophages by pretreatment with interferon.
    Giese M; Kirchner H
    Immunol Lett; 1988 Jun; 18(2):109-13. PubMed ID: 3403000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of a lack of enteric side-effects induced by DEAE-dextran in man.
    Zuccato E; Mussini E; Spignoli G; Pupita F
    Pharmacol Res Commun; 1987 Aug; 19(8):547-53. PubMed ID: 2448833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of tRNA on interferon induction by poly I:C in Lpa cells.
    Zahorska R; Korbecki M; Barciszewski J; Gołaszewska E
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):43-8. PubMed ID: 7149926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.